Skip to main content
SpringerLink
Log in

Malignancies of the Ovary

  • Chapter
Cancer in Adolescents and Young Adults

Part of the book series: Pediatric Oncology ((PEDIATRICO))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bleyer WA O’Leary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767, Bethesda MD; also available at www.seer.cancer.gov/publications

    Google Scholar 

  2. Brown J, Shvartsman HS, Deavers MT, et al (2004b) The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. J Clin Oncol 22:3517–3523

    Article  PubMed  CAS  Google Scholar 

  3. Raney RB Jr, Sinclair L, Uri A, et al (1987) Malignant ovarian tumors in children and adolescents. Cancer 59:1214–1220

    Article  PubMed  Google Scholar 

  4. Bernstein L, Smith MA, Liu L, et al (1999) Germ cell, trophoblastic and other gonadal neoplasms ICCC X. In: Ries AG, Smith MA, Gurney JG, et al (eds) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH Pub. No. 99-4649. Bethesda: National Cancer Institute, SEER Program, pp 139–147

    Google Scholar 

  5. Serov SF, Scully RE, Robin IH (1973) Histological Typing of Ovarian Tumors: International Histological Classification of Tumors, World Health Organization, Geneva, No. 9

    Google Scholar 

  6. Young JL Jr, Wu XC, Roffers SD, et al (2003) Ovarian cancer in children and young adults in the United States, 1992–1997. Cancer 97: 2694–2700

    Article  PubMed  Google Scholar 

  7. Morowitz M, Huff D, von Allmen D (2003) Epithelial ovarian tumors in children: a retrospective analysis. J Pediatr Surg 38:331–335

    Article  PubMed  Google Scholar 

  8. Fotiou SK (1997) Ovarian malignancies in adolescence. Ann NY Acad Sci 816:338–346

    Article  PubMed  CAS  Google Scholar 

  9. Williams SD, Gershenson DM, Horowitz CJ, et al (2000) Ovarian GCT. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology (3rd edn). Lippincott Williams and Wilkins, Philadelphia, pp 1059–1073

    Google Scholar 

  10. Emans SJH, Laufer MF, Goldstein DP (eds) (1998) Pediatric and Adolescent Gynecology (4th edn). Lippincott-Raven, Philadelphia, p 562

    Google Scholar 

  11. Cushing B, Giller R, Cullen JW, et al (2004) Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric inter-group study — Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol 22:2691–2700

    Article  PubMed  CAS  Google Scholar 

  12. Rogers PC, Olson TA, Cullen JW, et al (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study — Pediatric Oncology Group 9048 and Children’s Cancer Group 8891. J Clin Oncol 22:3563–3569

    Article  PubMed  Google Scholar 

  13. Castedo SM, de Jong B, Oosterhuis JW, et al (1989) Chromosomal changes in human primary testicular nonseminomatous germ cell tumors. Cancer Res 49:5696–5701

    PubMed  CAS  Google Scholar 

  14. Riopel MA, Spellerberg A, Griffin CA, et al (1998) Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res 58:3105–3110

    PubMed  CAS  Google Scholar 

  15. Samaniego F, Rodriguez E, Houldsworth J, et al (1990) Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer 1:289–300

    Article  PubMed  CAS  Google Scholar 

  16. Bussey KJ, Lawce HJ, Olson SB, et al (1999) Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences — a Children’s Cancer Group study. Genes Chromosomes Cancer 25:134–146

    Article  PubMed  CAS  Google Scholar 

  17. Perlman EJ, Hu J, Ho D, et al (2000) Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization. J Pediatr Hematol Oncol 22:100–105

    Article  PubMed  CAS  Google Scholar 

  18. Schneider DT, Schuster AE, Fritsch MK, et al (2001) Multipotent imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61:7268–7276

    PubMed  CAS  Google Scholar 

  19. Schneider DT, Schuster AE, Fritsch MK, et al (2001) Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr 213:204–211

    Article  PubMed  CAS  Google Scholar 

  20. Koonings PP, Campbell K, Mishell DR Jr, et al (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74:921–926

    PubMed  CAS  Google Scholar 

  21. Duska LR, Chang Y, Flynn CE (1999) Epithelial ovarian cancer in the reproductive age group. Cancer 85:2623–2629

    Article  PubMed  CAS  Google Scholar 

  22. Hogg R, Friedlander M (2004) Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J Clin Oncol 22:1315–1327

    Article  PubMed  Google Scholar 

  23. Taylor HC (1929) Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 48:204–230

    Google Scholar 

  24. Lawrence WD (1995) The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of ‘borderline’ ovarian tumors. Cancer 76:2138–2142

    Article  PubMed  CAS  Google Scholar 

  25. Katsube Y, Berg JW, Silverberg SG (1982) Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area 1 July-31 December 1969 and 1 July–31 December 1979. Int J Gynecol Pathol 1:3–16

    PubMed  CAS  Google Scholar 

  26. Scully RE (1982) Common epithelial tumors of borderline malignancy. Bull Cancer (Paris) 69:228–238

    PubMed  CAS  Google Scholar 

  27. Kohlberger PD, Kieback DG, Mian C, et al (1997) Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. J Soc Gynecol Invest 4:262–264

    Article  CAS  Google Scholar 

  28. Gribbon, M, Ein SH, Mancer K (1992) Pediatric malignant ovarian tumors: a 43-year review. J Pediatr Surg 27:480–484

    Article  PubMed  CAS  Google Scholar 

  29. Lacson AG, Gillis DA, Shawwa A (1988) Malignant mixed germ-cell-sex cord-stromal tumors of the ovary associated with isosexual precocious puberty. Cancer 61:2122–2133

    Article  PubMed  CAS  Google Scholar 

  30. Scully RE (1970) Sex cord tumor with annular tubules: a distinctive ovarian tumor of the Peutz-Jeghers syndrome. Cancer 25:1107–1121

    Article  PubMed  CAS  Google Scholar 

  31. Young RH, Welch WR, Dickersin GR, Scully RE (1982) Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 50:1384–1402

    Article  PubMed  CAS  Google Scholar 

  32. Berek JS, Hacker NF (eds) (1994) Nonepithelial ovarian and fallopian tube cancers. In: Practical Gynecologic Oncology (2nd edn). Williams and Wilkins, Baltimore, pp 380–381

    Google Scholar 

  33. Tewari K, Cappuccini F, Disaia PJ, et al (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95:128–133

    Article  PubMed  CAS  Google Scholar 

  34. Bjorkholm E, Silfversward C (1981) Prognostic factors in granulosa-cell tumors. Gynecol Oncol 11:261–274

    Article  PubMed  CAS  Google Scholar 

  35. Vergote I, De Brabanter J, Fyles A, et al (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176–182

    Article  PubMed  CAS  Google Scholar 

  36. Billmire D, Vinocur C, Rescorla F, et al (2004) Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 39:424–429

    Article  PubMed  CAS  Google Scholar 

  37. Abu-Rustum NR, Aghajanian C (1998) Management of malignant germ cell tumors of the ovary. Semin Oncol 25:235–242

    PubMed  CAS  Google Scholar 

  38. Gershenson DM (1994) Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 55:S62–72

    Article  PubMed  CAS  Google Scholar 

  39. Cannistra SA (1993) Cancer of the ovary. N Engl J Med 329:1550–1559

    Article  PubMed  CAS  Google Scholar 

  40. International Federation of Gynecology and Obstetrics (1987) Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156:263–264

    Google Scholar 

  41. Baranzelli MC, Flamant F, De Lumley L, et al (1993) Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the “Societe Francaise d’Ongologie Pediatrique” MGCT 1985–1989 study. Med Pediatr Oncol 21:395–401

    Article  PubMed  CAS  Google Scholar 

  42. Gobel U, Calaminus G, Haas RJ, et al (1989) Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83). Cancer Chemother Pharmacol 24:34–39

    Article  Google Scholar 

  43. Mann JR, Raafat T, Robinson K, et al (2000) The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 18:3809–3818

    PubMed  CAS  Google Scholar 

  44. Gershenson DM (1994) Editorial: The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors. Gynecol Oncol 52:283–285

    Article  PubMed  CAS  Google Scholar 

  45. Disaia PJ, Creasman WT (eds) (2002) Germ cell, stromal, and other ovarian tumors. In: Clinical Gynecologic Oncology (6th edn). Mosby, St. Louis, MO, pp 362–363

    Google Scholar 

  46. Brewer M, Gershenson DM, Herzog CE, et al (1999) Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17:2670–2675

    PubMed  CAS  Google Scholar 

  47. Schumer ST, Cannistra SA (2003) Granulosa cell tumor of the ovary. J Clin Oncol 21:1180–1189

    Article  PubMed  Google Scholar 

  48. Pfleiderer A (1993) Therapy of ovarian malignant germ cell tumors and granulosa tumors. Int J Gynecol Pathol 12:162–165

    PubMed  CAS  Google Scholar 

  49. Colombo N, Chiari S, Maggioni A, et al (1994) Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 55:S47–S51

    Article  PubMed  CAS  Google Scholar 

  50. Le T, Krepart GV, Lotocki RJ, Heywood MS (1999) Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly? Gynecol Oncol 74:252–254

    Article  PubMed  CAS  Google Scholar 

  51. Hoskins WJ (1994) Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91–96

    Article  PubMed  CAS  Google Scholar 

  52. Lin PS, Gershenson DM, Bevers MW, et al (1999) The current status of surgical staging of ovarian serous borderline tumors. Cancer 85:905–911

    Article  PubMed  CAS  Google Scholar 

  53. Yazigi R, Sandstad J, Munoz AK (1988) Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 31:402–408

    Article  PubMed  CAS  Google Scholar 

  54. Gershenson DM, Silva EG, Levy L, et al (1998) Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82:1096–1103

    Article  PubMed  CAS  Google Scholar 

  55. Williams S, Blessing JA, Liao S-Y, et al (1994) Adjuvant therapy of ovarian GCT with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12:701–706

    PubMed  CAS  Google Scholar 

  56. Marina NM, Cushing B, Giller R, et al (1999) Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol 17:2137–2143

    PubMed  CAS  Google Scholar 

  57. Dark GG, Bower M, Newlands ES, et al (1997) Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620–624

    PubMed  CAS  Google Scholar 

  58. Gobel U, Calaminus G, Haas RJ, et al (2000) Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11:263–271

    Article  PubMed  CAS  Google Scholar 

  59. Gershenson DM, Copeland LJ, del Junco, et al (1986) Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Cancer 67:789–793

    CAS  Google Scholar 

  60. Munkarah A, Gershenson DM, Levenback C, et al (1994) Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 55:217–223

    Article  PubMed  CAS  Google Scholar 

  61. Homesley HD, Bundy BN, Hurteau JA, et al (1999) Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 72:131–137

    Article  PubMed  CAS  Google Scholar 

  62. Brown J, Shvartsman HS, Deavers MT, et al (2004) Taxane-based chemotherapy compared with bleomycin, etoposide, and cisplatin for the treatment of sex cordstromal ovarian tumors. Gynecol Oncol 92:402

    Google Scholar 

  63. Fishman A, Kudelka AP, Tresukosol D, et al (1996) Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41:393–396

    PubMed  CAS  Google Scholar 

  64. Young RH, Scully RE (1984) Ovarian Sertoli cell tumors: a report of 10 cases. Int J Gynecol Pathol 2:349–363

    Article  PubMed  CAS  Google Scholar 

  65. Gershenson DM, Morris M, Burke TW, et al (1996) Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 87:527–531

    Article  PubMed  CAS  Google Scholar 

  66. Srivatsa PJ, Keeney GL, Podratz KC (1994) Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol 53:256–264

    Article  PubMed  CAS  Google Scholar 

  67. Gershenson DM, Copeland LJ, Kavanagh JJ, et al (1987) Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 70:765–769

    PubMed  CAS  Google Scholar 

  68. Hartmann LC, Young RH, Podratz KC. (2000) Ovarian sex cord-stromal tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology (3rd edn). Lippincott Williams and Wilkins, Philadelphia, pp 1075–1097

    Google Scholar 

  69. Deavers MT, Gershenson DM, Tortolero-Luna G, et al (2002) Micropapillary and cribiform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol 26:1129–1141

    Article  PubMed  Google Scholar 

  70. Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404–2419

    Article  PubMed  CAS  Google Scholar 

  71. Marina N, Fontanesi J, Jun L, et al (1992) Treatment of childhood germ cell tumors: review of the St. Jude experience from 1979–1988. Cancer 70:2568–2575

    Article  PubMed  CAS  Google Scholar 

  72. Susnerwala SS, Pande SC, Shrivastava SK, Dinshaw KA (1991) Dysgerminoma of the ovary: review of 27 cases. J Surg Oncol 46:43–47

    Article  PubMed  CAS  Google Scholar 

  73. Gershenson DM, Morris M, Cangir A, et al (1990) Treatment of malignant GCT of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8:715–720

    PubMed  CAS  Google Scholar 

  74. La Polla JP, Brenda J, Vigliotti AP, Anderson B (1987) Dysgerminoma of the ovary. Obstet Gynecol 69:859–864

    Google Scholar 

  75. Baranzelli MC, Bouffet E, Quintana E, et al (2000) Nonseminomatous ovarian germ cell tumours in children. Eur J Cancer 36:376–383

    Article  PubMed  CAS  Google Scholar 

  76. Murphy BA, Motzer RJ, Mazumdar M, et al (1994) Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer 73:2520–2526

    Article  PubMed  CAS  Google Scholar 

  77. Schneider DT, Janig M, Calaminus, et al (2003) Ovarian sex-cord stromal tumors — a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry. Virchows Arch 443:549–560

    Article  PubMed  Google Scholar 

  78. Tsai JY, Saigo PE, Brown C, La Quaglia MP (2001) Diagnosis, pathology, staging, treatment, and outcome of epithelial ovarian neoplasia in patients age < 21 years. Cancer 91:2065–2070

    Article  PubMed  CAS  Google Scholar 

  79. Demeter A, Csapo Z, Szantho A, et al (2002) A retrospective study of 27 ovarian tumors of low malignant potential. Eur J Gynaecol Oncol XXIII:415–418

    Google Scholar 

  80. DeCherney AH, Nathan L (2003) Current Obstetric and Gynecologic Diagnosis and Treatment (9th edn). Lange Medical Books/McGraw-Hill, New York, p 612

    Google Scholar 

  81. Plante M (2000) Fertility preservation in the management of gynecologic cancers. Curr Opin Oncol 12:497–507

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Tx, 77030, USA

    Jubilee Brown M.D.

  2. Division of Pediatric Hematology/Oncology, Childrens Healthcare of Atlantiat Egleston, 2015 Uppergate Drive, Atlanta, GA, 3022, USA

    Thomas Olson M.D.

  3. Children’s Hospitals and Clinics of Minnesota, 2525 Chicago Ave. S, Minneapolis, MN, 55404, USA

    Susan Sencer M.D.

Authors
  1. Jubilee Brown M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Olson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Sencer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Charles Medical Center, Bend, Oregon, USA

    W. Archie Bleyer

  2. McMaster University, Hamilton, Ontario, Canada

    Ronald D. Barr

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Brown, J., Olson, T., Sencer, S. (2007). Malignancies of the Ovary. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68152-6_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40842-0

  • Online ISBN: 978-3-540-68152-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation